Target intelligence / Profile preview

Glycoprotein H of human cytomegalovirus (gH (commonly used in scientific literature, especially when referring to herpesvirus glycoprotein complexes))

Target
gH (commonly used in scientific literature, especially when referring to herpesvirus glycoprotein complexes)
Molecular classification
Viral envelope glycoprotein, Fusion cofactor; part of the viral entry machinery, Other (exists as a complex with Glycoprotein L and either UL128-131 or gO, creating distinct molecular complexes)
01

Overview

Glycoprotein H of human cytomegalovirus is a type I transmembrane viral envelope protein encoded by UL75. It forms heterodimers with glycoprotein L (gL) and can combine with additional subunits (such as gO or UL128-131 family proteins), resulting in complexes that mediate virus entry into host cells[2][5][6][7]. The gH/gL complex functions by binding specific cellular receptors, thereby regulating the tropism of the virus and triggering membrane fusion by activating glycoprotein B (gB)[5][6][7]. These functions are critical for the initial infection of epithelial, endothelial, and other cell types, as well as cell-to-cell viral spread. gH, particularly as part of the gH/gL/UL128-131 complex, is a major antigenic target for neutralizing antibodies and candidate vaccines aiming to block CMV transmission and pathogenesis[6][7].

Other names
gH (glycoprotein H)gpUL75 (gene product reference in HCMV)HCMV gHHCMV envelope glycoprotein H
02

Mechanism of action

Inhibition of viral entry by blocking fusion and receptor interaction Neutralization of the virus by preventing binding to epithelial/endothelial cell receptors (antibody/vaccine responses)

03

Biological functions

Mediates viral entry by promoting membrane fusionForms complexes (e.g., gH/gL, gH/gL/UL128-131) that bind to host cell receptors and determine cell tropismEssential for infection of epithelial, endothelial, and other cell typesFacilitates cell-to-cell viral spread
04

Disease associations

Infection (central to human cytomegalovirus infection and pathogenesis)Other (no direct implication in cancer or non-infectious diseases)
05

Safety considerations

Targeting glycoprotein H for therapeutic or vaccine purposes must avoid excessive immune activation or off-target autoimmunity (general concern for viral envelope proteins). No specific safety issues have been reported for gH itself
06

Interacting drugs

No approved drugs currently directly target glycoprotein H, but it is a key antigen in vaccine research. Neutralizing monoclonal antibodies to gH/gL/UL128-131 are being developed as antivirals and prophylactics

1 more in the full profile.

07

Biomarkers

Antibody titers against gH/gL/UL128-131 are sometimes used as markers of immune response post-vaccination or during CMV infection, but no established clinical biomarker for patient selection exists

Beyond the preview

Go deeper on Glycoprotein H of human cytomegalovirus (gH (commonly used in scientific literature, especially when referring to herpesvirus glycoprotein complexes)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycoprotein H of human cytomegalovirus (gH (commonly used in scientific literature, especially when referring to herpesvirus glycoprotein complexes)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call